Santo SS, Sergio N, Giuseppe M, Margherita F, Gea OC, Roberto F, et al
When is dermatology referral appropriate
Those who maintained their baseline diet without additional effort still observe fat reduction, though at a more modest rate
Additionally, PDTs enable customized patient engagement strategies, such as drug-specific education and adverse event support, ensuring patients remain engaged throughout their treatment journey
This triple agonist design, developed by Eli Lilly under the research code LY3437943, represents a fundamentally different approach from semaglutide (which targets only GLP-1) or tirzepatide (which targets GLP-1 and GIP)
However, semaglutide has proven cardiovascular benefits (SELECT trial) which are important for many diabetes patients